14-day Premium Trial Subscription Sign Up For FreeGet Free

Chiasma Stock Forecast NASDAQ:CHMA

Price Target and Analyst Ratings

Most Recent Rating

HC Wainwright is very positive about CHMA and gave it a "Buy" rating on March 02, 2021. The price target was changed from $10.00 to $12.00.

Last 30 Days

Historical Ratings

Date Rating Action Authority Current Price Target Price
2021-05-06 Buy - Hold Downgraded by Jefferies Financial Group $3.98
2021-05-05 Overweight - Neutral Downgraded by Piper Sandler $3.98
2021-03-02 Buy Target Raised by HC Wainwright $3.99 $10.00 → $12.00
2021-03-02 Buy Reiterated by HC Wainwright $3.99 $10.00 → $12.00
2021-01-11 Target Lowered by Piper Sandler $4.07 $19.00 → $15.00
2021-01-08 Buy Reiterated by HC Wainwright $4.19 $10.00
2020-08-13 Buy Initiated by Jefferies Financial Group $4.50 $8.00
2020-08-12 Buy Target Lowered by HC Wainwright $4.44 $11.00 → $10.00
2020-08-12 Buy Target Lowered by HC Wainwright $4.44 $11.00 → $10.00
2020-07-07 Target Lowered by Piper Sandler $4.66 $22.00 → $19.00
2020-06-29 Buy Target Raised by HC Wainwright $5.62 $10.00 → $11.00

CHMA Stock Trend

The stock lies in the middle of a wide and falling trend in the short term and further fall within the trend is signaled.

Given the current short-term trend, the stock is expected to fall -19.93% during the next 3 months and, with a 90% probability hold a price between $2.65 and $3.11 at the end of this 3-month period. Do note, that if the stock price manages to stay at current levels or higher, our prediction target will start to change positively over the next few days as the conditions for the current predictions will be broken.

Data

Date Bottom Mid Top
2021-09-20 $3.30 $3.59 $3.87
2021-09-21 $3.28 $3.57 $3.86
2021-09-22 $3.27 $3.56 $3.84
2021-09-23 $3.25 $3.54 $3.83
2021-09-24 $3.24 $3.52 $3.81
2021-09-27 $3.22 $3.51 $3.80
2021-09-28 $3.21 $3.49 $3.78
2021-09-29 $3.19 $3.48 $3.77
2021-09-30 $3.18 $3.46 $3.75
2021-10-01 $3.16 $3.45 $3.73
2021-10-04 $3.15 $3.43 $3.72
2021-10-05 $3.13 $3.42 $3.70
2021-10-06 $3.11 $3.40 $3.69
2021-10-07 $3.10 $3.39 $3.67
2021-10-08 $3.08 $3.37 $3.66
2021-10-11 $3.07 $3.36 $3.64
2021-10-12 $3.05 $3.34 $3.63
2021-10-13 $3.04 $3.32 $3.61
2021-10-14 $3.02 $3.31 $3.60
2021-10-15 $3.01 $3.29 $3.58
2021-10-18 $2.99 $3.28 $3.57
2021-10-19 $2.98 $3.26 $3.55
2021-10-20 $2.96 $3.25 $3.53
2021-10-21 $2.95 $3.23 $3.52
2021-10-22 $2.93 $3.22 $3.50
2021-10-25 $2.92 $3.20 $3.49
2021-10-26 $2.90 $3.19 $3.47
2021-10-27 $2.88 $3.17 $3.46
2021-10-28 $2.87 $3.16 $3.44
2021-10-29 $2.85 $3.14 $3.43

About Chiasma

Chiasma Chiasma, Inc., a late-stage biopharmaceutical company, focuses on developing and commercializing oral forms of therapies for patients suffering from orphan diseases. Its product candidate is octreotide capsules or MYCAPSSA, which has completed Phase III clinical trial for the treatment of acromegaly, a condition that results in the body’s production of excess growth hormone. Chiasma, Inc. was founded in 2001 and is headquartered in Newton, Massa... Read more

Golden Star Signal

This unique signal uses moving averages and adds special requirements that convert the very good Golden Cross into a Golden Star.

This signal is rare and, in most cases, gives substantial returns. From 10 000+ stocks usually only a few will trigger a Golden Star Signal per day!

Get access to Golden Star list now!

StockInvest.usJoin 95.000+ Happy Subscribers

Don't miss out on the runners!

Get The StockInvest.Us Newsletter

StockInvest.usStock Podcast

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT